Science, medicine, and the future - Pharmacogenetics

被引:165
作者
Wolf, CR [1 ]
Smith, G
Smith, RL
机构
[1] Univ Dundee, Ninewells Hosp & Med Sch, Imperial Canc Res Fund, Mol Pharmacol Unit, Dundee DD1 9SY, Scotland
[2] Univ Dundee, Ninewells Hosp & Med Sch, Biomed Res Ctr, Dundee DD1 9SY, Scotland
[3] Univ London Imperial Coll Sci Technol & Med, Sch Med, Div Biomed Sci, Sect Mol Toxicol, London SW7 2AZ, England
关键词
D O I
10.1136/bmj.320.7240.987
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:987 / 990
页数:4
相关论文
共 13 条
[1]   Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications [J].
Aithal, GP ;
Day, CP ;
Kesteven, PJL ;
Daly, AK .
LANCET, 1999, 353 (9154) :717-719
[2]  
BERTILSSON L, 1993, LANCET, V341, P363
[3]  
CHOU WH, IN PRESS J CLIN PSYC
[4]  
*DAT, 1999, ABPI COMP DAT SHEETS
[5]   INHERITED AMPLIFICATION OF AN ACTIVE GENE IN THE CYTOCHROME-P450 CYP2D LOCUS AS A CAUSE OF ULTRARAPID METABOLISM OF DEBRISOQUINE [J].
JOHANSSON, I ;
LUNDQVIST, E ;
BERTILSSON, L ;
DAHL, ML ;
SJOQVIST, F ;
INGELMANSUNDBERG, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (24) :11825-11829
[6]   Genetic polymorphism of thiopurine S-methyltransferase: Clinical importance and molecular mechanisms [J].
Krynetski, EY ;
Tai, HL ;
Yates, CR ;
Fessing, MY ;
Loennechen, T ;
Schuetz, JD ;
Relling, MV ;
Evans, WE .
PHARMACOGENETICS, 1996, 6 (04) :279-290
[7]   Incidence of adverse drug reactions in hospitalized patients - A meta-analysis of prospective studies [J].
Lazarou, J ;
Pomeranz, BH ;
Corey, PN .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (15) :1200-1205
[8]   GENETIC-VARIATION IN RESPONSE TO 6-MERCAPTOPURINE FOR CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA [J].
LENNARD, L ;
LILLEYMAN, JS ;
VANLOON, J ;
WEINSHILBOUM, RM .
LANCET, 1990, 336 (8709) :225-229
[9]  
*MED EC, 1999, PHYS DESK REF 2000
[10]  
Vogel F., 1959, ERG INN MED KINDERHK, P52, DOI DOI 10.1007/978-3-642-94744-5_2